glp-1 medications mechanism of action glp-1_analogs [TUSOM GLP-1 Therapy Part 1: Setting

For the vast majority of people, morning dosing produces the best results with the fewest complications

On the contrary, a systematic review on mortality, as well as cardiovascular and kidney statuses in patients with T2DM treated with GLP-1RAs concluded that there was no increase in the incidence of severe hypoglycaemia, pancreatitis, or pancreatic cancer (222)

Recently, GLP-1RAs have been approved for the treatment of obesity and recognized for their cardioprotective effects

Zepbound trial data in its prescribing information reported constipation in 11% to 17% of treatment groups across labeled doses

FEBS Lett (1981) 129(1):12730

doi: 10.1056/NEJMoa1406656 80 DarsaliaVKleinTNystrmTPatroneC